Rx Item-Brevibloc 10MG/ML 25X10 ML Single Dose Vial by Baxter Pharma USA

BREVIBLOC- esmolol hydrochloride injection, solution
General Injectables & Vaccines
Supraventricular Tachycardia or Noncompensatory Sinus Tachycardia
BREVIBLOC (Esmolol Hydrochloride) is indicated for the rapid control of ventricular rate in patients with atrial fibrillation or atrial flutter in perioperative, postoperative, or other emergent circumstances where short term control of ventricular rate with a short-acting agent is desirable. BREVIBLOC is also indicated in noncompensatory sinus tachycardia where, in the physician's judgment, the rapid heart rate requires specific intervention. BREVIBLOC is intended for short-term use.
Intraoperative and Postoperative Tachycardia and/or Hypertension
BREVIBLOC (Esmolol Hydrochloride) is indicated for the short-term treatment of tachycardia and hypertension that occur during induction and tracheal intubation, during surgery, on emergence from anesthesia and in the postoperative period, when in the physician's judgment such specific intervention is considered indicated.
Use of BREVIBLOC to prevent such events is not recommended.
Dosing for the Treatment of Supraventricular Tachycardia or Noncompensatory Sinus Tachycardia
BREVIBLOC is administered by continuous intravenous infusion with or without a loading dose. Additional loading doses and/or titration of the maintenance infusion (step-wise dosing) may be necessary based on desired ventricular response.
In the absence of loading doses, continuous infusion of a single concentration of esmolol reaches pharmacokinetic and pharmacodynamic steady-state in about 30 minutes.
The effective maintenance dose for continuous and step-wise dosing is 50 to 200 mcg per kg per minute, although doses as low as 25 mcg per kg per minute have been adequate. Dosages greater than 200 mcg per kg per minute provide little added heart rate lowering effect, and the rate of adverse reactions increases.
Maintenance infusions may be continued for up to 48 hours.
How Supplied
BREVIBLOC PREMIXED Injection
NDC 10019-055-61, 2500 mg / 250 mL (10 mg/mL) Ready-to-use INTRAVIA Bags
BREVIBLOC DOUBLE STRENGTH PREMIXED Injection
NDC 10019-075-87, 2000 mg / 100 mL (20 mg/mL) Ready-to-use INTRAVIA Bags
BREVIBLOC Injection
NDC 10019-115-01, 100 mg / 10 mL (10 mg/mL) Ready-to-use Vials, Package of 25
Storage
Store at 25�C (77�F). Excursions permitted to 15�-30�C (59�-86�F) [see USP Controlled Room Temperature]. Protect from freezing. Avoid excessive heat.
Each bag contains no preservative. Once drug has been withdrawn from ready-to-use bag, the bag should be used within 24 hours, with any unused portion discarded.
Do not use plastic containers in series connections. Such use could result in an embolism due to residual air being drawn from the primary container before administration of the fluid from the secondary container is completed.
Do not remove unit from overwrap until ready to use. Do not use if overwrap has been previously opened or damaged. The overwrap is a moisture barrier. The inner bag maintains sterility of the solution. Tear overwrap at notch and remove premixed bag. Some opacity of the plastic due to moisture absorption during the sterilization process may be observed. This is normal and does not affect the solution quality or safety. The opacity will diminish gradually.
Check for minute leaks by squeezing the inner bag firmly. If leaks are found, discard solution, as sterility may be impaired. Do not use unless the solution is clear (colorless to light yellow) and the seal is intact.
Preparation for intravenous administration:
Use aseptic technique
Suspend premixed bag from eyelet support.
Remove plastic protector from delivery port at bottom of bag.
Attach administration set.
Refer to complete directions accompanying set.
PATIENT COUNSELING INFORMATION
Physicians should inform patients of the risks associated with BREVIBLOC injection:
The most common adverse reactions are symptomatic hypotension (hyperhidrosis, dizziness) and asymptomatic hypotension.

Rx Item-Brevibloc 10MG/ML 25X10 ML Singl
Item No. RX792832, 792832, NDC No.: 10019-0115-01, 10019-115-01, 1001911501, 10019011501, 0115-01, 011501 UPC No. 3-10019-11501-6, 310019-115016, 310019115016

Rx Item-Brevibloc 10MG/ML 25X10 ML Singl
Item No. RX792832, 792832, NDC No.: 10019-0115-01, 10019-115-01, 1001911501, 10019011501, 0115-01, 011501 UPC No. 3-10019-11501-6, 310019-115016, 310019115016

Rx Item-Brevibloc 10MG/ML 25X10 ML Singl
Rx items can only be ordered by a valid licence holder in scope of practice by-Physician,Pharmacy,Dentist,Drug Mfg,Dist.,Gov,Hospital,Lic.Lab,Naturalist,Naturopath,NP,Optometrist,Pharmacist,PA,Physica

Buy More Save More!
Want to do Research on this Med or need a large quantity? Email Details with quantity required to:[email protected]

AmericanPharmaWholesale.com
Visit AmericanPharmaWholesale.com for over 100,000 items of Health & Beauty at Retail@Wholesale prices.